ÈÈÃű¬ÁÏ

ÈÈÃű¬ÁÏ. (2025).
Letter to FDA re Draft Guidance on Considerations for Use of AI.
Retrieved from /advocacy/testimony-and-correspondence/letter-to-fda-re-draft-guidance-on-considerations-for-use-of-ai.

ÈÈÃű¬ÁÏ.
"Letter to FDA re Draft Guidance on Considerations for Use of AI." Hematology.org.
/advocacy/testimony-and-correspondence/letter-to-fda-re-draft-guidance-on-considerations-for-use-of-ai
(label-accessed June 02, 2025).

"ÈÈÃű¬ÁÏ."
Letter to FDA re Draft Guidance on Considerations for Use of AI, 02 Jun. 2025 ,
/advocacy/testimony-and-correspondence/letter-to-fda-re-draft-guidance-on-considerations-for-use-of-ai.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero